Specialty Pharmacy

Stephen Vogt, PharmD, Chief Executive Officer and President of BioPlus Specialty Pharmacy, discusses how BioPlus has changed to better meet the needs of their patients.

Program allows health care professionals to better access medication history.

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the long term impact of the Affordable Care Act on specialty pharmacies.

Researchers find interventions targeting mental health problems and substance abuse can improve treatment outcomes.

Caregivers give thoughts on attributes they are looking for in DMD treatment.

Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy discusses effective counseling of rheumatoid arthritis patients on biologic DMARD therapy.

Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men's treatment decisions after seeing a rise in their PSA levels.

This National Cancer Institute video provides key facts and statistics on prostate cancer diagnosis and treatment.

This presentation by Michael S. Cookson, MD, MMHC, vice chairman and Hart Professor of Urologic Surgery at Vanderbilt University Medical Center, addresses prostate cancer treatment options for 6 common clinical scenarios.

Charles M. Perou, PhD, professor of genetics, pathology & laboratory medicine, UNC Lineberger Comprehensive Cancer Center, discusses a trial (CALGB 40601) presented at the 2014 ASCO Annual Meeting.

Nancy Lin, MD, of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, discusses the differences between breast cancer subtypes and looks at recent drug approvals and research directions for the future.

This presentation by Carol DeSantis, MPH, an epidemiologist with the American Cancer Society (ACS), covers key findings and statistics from the ACS report "Breast Cancer Facts and Figures 2013-2014."

In this video, Douglas Lienesch, MD, assistant professor in the division of rheumatology and clinical immunology at the University of Pittsburgh Medical Center, offers an overview of available medications for the treatment of psoriatic arthritis.

Philip Mease, MD, director of rheumatology research at Swedish Medical Center and clinical professor at the University of Washington School of Medicine in Seattle, discusses key points regarding the diagnosis and treatment of psoriatic arthritis in this video produced by the Cleveland Clinic Center for Continuing education.

In this video produced by the National Psoriasis Foundation, experts offer their insights into improving outcomes for psoriatic arthritis patients.

Researchers seek improved biomarkers to distinguish between malignant and benign disease.

Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses the questions specialty providers need to address to reach consumers in the changing health care landscape.

Deborah Cmielewski, Esq., vice president and general counsel at Armada Health Care, discusses key issues regarding HI-Tecj/HIPAA legislation for specialty pharmacies.

Cardiovascular risk related to severity of inflammation, but not associated with disease duration.

Leigh Ann Bruhn, director of Avalere Health, discusses how specialty pharmacies can help achieve the goals of accountable care groups.

Patients with psoriasis, psoriatic arthritis, or both conditions felt that their quality of life decreased if they experienced condition symptoms in more parts of their body.

The United States stands to be a key player in the global oncology biosimilars market, which is predicted to generate up to $12 billion in revenue by 2020.

Drug seeks to mitigate challenge of infusion frequency while protecting against bleeding episodes.

Michael Einodshofer, RPh, MBA, senior director of specialty strategy and innovation at Walgreens, discusses the potential impact of specialty medications on overall drug spending.

According to a retrospective study and a registry analysis, statin therapy may reduce the rate of local breast cancer recurrence in certain types of breast cancer.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses emerging trends in the treatment of cancer that specialty pharmacies need to be aware of.

LBH589, when used in combination with bortezomib and dexamethasone, improved progression-free survival among relapsed and refractory patients with multiple myeloma.

A genetic test in development by Micromedic may help identify patients who are likely to develop bisphosphonate-associated osteonecrosis of the jaw.

Shannon Ambrose, senior director of Specialty Solutions at Prime Therapeutics, discusses the factors that negatively impact medication adherence for specialty drugs.

Patients with prostate cancer may benefit from bone mineral density screenings prior to initiation of therapy, researchers concluded.